You are here: Industry Insights > Dengvaxia

News List

Philippines officials nix Sanofi's attempt to bring Dengvaxia back to market fiercepharma
August 25, 2019
Sanofi has been through an ordeal with its Dengvaxia rollout in the Philippines, but earlier this month, it looked as if officials might reintroduce the dengue vaccine to battle a deadly outbreak. For now, though, that's off the table.
Philippine officials consider Sanofi's Dengvaxia—again—amid deadly outbreak fiercepharma
August 13, 2019
It’s hard to imagine Sanofi’s Dengvaxia rollout in the Philippines going worse than it did, what with investigations and allegations that the shot caused deaths in children. But authorities are considering introducing the vaccine again to fight an outbrea
FDA Approves Dengvaxia (dengue vaccine) for the Prevention of Dengue Disease in Endemic Regions drugs
May 08, 2019
The U.S. Food and Drug Administration announced today the approval of Dengvaxia, the first vaccine approved for the prevention of dengue disease caused by all dengue virus serotypes (1, 2, 3 and 4) in ...
FDA Approves Dengvaxia drugs
May 06, 2019
FDA Approves Dengvaxia (dengue vaccine) for the Prevention of Dengue Disease in Endemic Regions.
Years into troubled launch, vaccine head says Sanofi's learned some Dengvaxia lessons fiercepharma
January 09, 2019
It's no secret that Sanofi has had a rough time marketing its world-first dengue vaccine, and at the J.P. Morgan Healthcare Conference, vaccine head David Loew told FiercePharma the company gleaned some lessons from the troubled launch.
Years into troubled launch, vaccine head says Sanofi's learned some Dengvaxia lessons fiercepharma
January 09, 2019
It's no secret that Sanofi has had a rough time marketing its world-first dengue vaccine, and at the J.P. Morgan Healthcare Conference, vaccine head David Loew told FiercePharma the company gleaned some lessons from the troubled launch.
Dengvaxia approved for dengue in EU pharmatimes
December 21, 2018
Dengvaxia will be available in Europe for individuals 9-45 years of age with a documented prior dengue infection, and who are living in endemic areas.
Sanofi's dengue shot Dengvaxia wins FDA priority review despite controversial past fiercepharma
October 31, 2018
Sanofi has weathered controversy with its world-first dengue vaccine, Dengvaxia, but the company is pressing ahead, and on Tuesday said the FDA had not only accepted its application for approval, but also granted a priority review.
Preliminary report outlines 'causal association' between Sanofi's Dengvaxia and 3 deaths fiercepharma
February 05, 2018
After months of controversy in the Philippines over Sanofi's Dengvaxia, an initial report has found a "causal association" between three deaths and the vaccine. Two of the deaths could have been a result of vaccine failure, according to the Philippine Gen
Philippines' Department of Health demands full refund of $70m Dengvaxia programme from Sanofi pharmafile
January 31, 2018
In the latest update of the Sanofi Philippines dengue vaccine scandal, the U.S. Department of Health demanded that French pharmaceutical companies pay a full refund of the three billion Philippine pesos paid by the Philippine government to immunize its ci

Previous page 1 2 Next page